D3S Group

What D3S Group does

D3S Group (legal entity: D3S a.s.) is a privately held Czech technology company founded in 2006, headquartered in Cercany with operating offices in Prague 4. The firm designs and develops custom software solutions, with deep specialization in pharmaceutical and life sciences customers, complemented by selected engagements in financial services, healthcare, energy, and technology. Its core product is Inception CRM, a proprietary cross-platform CRM platform (iOS, Android, Windows) built on the Microsoft technology stack (.NET, Xamarin Forms, SQL) with modular add-ons including Clinical Studies (CTMS for Phase III-IV trials with 21 CFR compliance), Tender Web (bid preparation), Closed Loop Marketing, eLearning, Knowledge Base, and a Direct Sales module featuring matrix code scanning. Two specialized products extend beyond CRM: Asan-Chek, a diabetes management app with native Bluetooth integration to Roche Accu-Chek glucometers, and Cogni, an iOS/Android cognitive health screening suite with predictive analytics for neurodegenerative disease detection.

The business operates on a hybrid revenue model combining project-based custom software development, product licensing of Inception CRM and its modules, and recurring managed services (application hosting, database hosting, and outsourced IT support). D3S serves enterprise clients via a consultative sales-led GTM with dedicated sales, partner relations, and key account management functions; pricing is quote-based with multi-year contracts typical of enterprise engagements. The company's customer base includes tier-1 multinational pharmaceutical names (Roche, Novartis, Sandoz, Allergan, Zentiva, Apotex, Sanofi-aventis, NAOS) plus selective non-pharma clients (Google, T-Mobile Czech Republic, Interactive Touch Systems, Prague Innovation Institute), with a self-reported footprint across 31 countries, 70+ client logos, 10,000+ users, and 40% year-over-year growth. Key differentiators include 18 years of pharma CRM domain expertise, regulatory fluency (GDPR, 21 CFR, GAMP5, US export controls), and EU jurisdiction that uniquely positions the firm to serve embargo-market clients such as those in Iran.

Name

D3S Group

Legal name

D3S a.s.

Website

https://d3s-group.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

D3S Group is a Czech IT services firm founded in 2006 that builds custom software and its proprietary Inception CRM platform primarily for pharmaceutical and life sciences clients across 31 countries. It combines project-based custom development, product licensing, and managed hosting with niche expertise in regulatory compliance and embargo-market delivery.

Ownership category

akta.pro rank

Product category

Pharmaceutical CRM & Healthcare Software

NAICS

Custom Computer Programming Services (541511), Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)

akta.pro primary industry

Industry-Specific CRM (Vertical CRM Suites) (HDAEAFAH)

akta.pro secondary industries

CRM Implementation & Customization Services (BPAEAGAC), CRM Managed Services & Support (BPAEAGAD), Customer Success & Account Management CRM (HDAEAFAD)

Keywords

• Pharmaceutical software solutions
• Custom CRM development
• Clinical trial management
• Healthcare IT services
• Pharma sales automation

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Custom Software Development Services: Bespoke software development services for enterprise clients requiring unique solutions. Revenue derived from project-based engagements including CRM implementation, custom application development, systems integration, and consulting services. Services span multiple industries with pharmaceutical sector as primary vertical.
2. Product Licensing (Inception CRM, Clinical Studies, etc.): Licensing of proprietary software products including Inception CRM, Clinical Studies CTMS, Tender Web, eLearning, and Knowledge Base platforms. Products deployed across enterprise client bases with implementation and customization services bundled.
3. IT Services and Hosting: Application hosting, database hosting, server hosting and management, and outsourced IT support services generating recurring revenue from ongoing service delivery.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

D3S Group designs, develops, and maintains custom software solutions for pharmaceutical, biotechnology, and healthcare companies. Its flagship offering is Inception CRM, a purpose-built customer relationship management platform tailored to pharma sales, marketing, and medical affairs workflows, complemented by adjacent modules such as Clinical Trial Management (CTMS), Tender Web, Orders Online, CLM, eLearning, and Knowledge Base. The firm also delivers bespoke software development and consulting services grounded in the Microsoft technology stack.

Product overview

D3S Group offers Inception CRM as its core unified platform for pharmaceutical and life sciences sales teams, with modular add-ons including Clinical Studies (CTMS), Tender Web (bid management), Orders Online (budget management), Closed Loop Marketing, eLearning, and Knowledge Base. The company's product portfolio also includes specialized applications: Cogni for cognitive health screening and monitoring, and Asan-Chek for diabetes management via glucometer integration. The architecture follows a platform-plus-modules model where Inception CRM serves as the central hub, with specialized modules extending functionality for specific use cases in pharma CRM, clinical trials, and healthcare.

Differentiator

Problem solved

Functional benefit

Brands

• Inception CRM: Robust and user-friendly CRM app for sales teams available on iPads, Android tablets, and Windows PCs. Supports customer research, plan optimization, activity reporting, multimedia presentations, order creation, promotional inventory management, and KPI tracking.
• Clinical Studies
• Tender Web
• Orders Online
• Closed Loop Marketing (CLM)
• eLearning
• Knowledge Base
• Cogni
• Asan-Chek

Products and services

• Inception CRM Industry-specific customer relationship management platform for pharmaceutical and biotech companies, covering sales force automation, medical affairs workflows, marketing, and reporting. Targets pharma commercial and medical teams in Central Europe.
• Clinical Studies (CTMS) Clinical Trial Management System for planning, tracking, and managing clinical studies, designed for pharma clinical operations teams.
• Tender Web Web module for managing pharmaceutical tenders and procurement processes, enabling pharma companies to handle public and institutional tenders.
• Orders Online Online ordering module that streamlines pharmaceutical order capture and processing for sales reps and distributors.
• CLM (Closed-Loop Marketing) Closed-loop marketing solution for medical representatives to deliver interactive presentations and capture engagement analytics during physician visits.
• eLearning E-learning platform for training pharmaceutical employees and medical representatives on products, compliance, and procedures.
• Knowledge Base Centralized knowledge base for organizing product information, medical content, and internal documentation for pharmaceutical companies.
• Cogni Cogni is a D3S product offering aimed at pharmaceutical industry information and intelligence workflows.
• Asan-Chek Asan-Chek is a D3S product offering supporting pharmaceutical operational or compliance workflows.
• Custom Software Development Services Bespoke software design, development, and consulting services for pharmaceutical, biotech, and healthcare clients whose needs extend beyond the standard Inception suite.

Quantifiable outcome

• Google's market share increased from 24% to 71% in Czech Republic search market through iGoogle strategic alliance
• +4 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• RochecoreStrategic or Co-development PartnerD3S developed the 'Asan-Chek' diabetes management app for Roche, syncing with Roche glucometers (Accu-Chek and Accu-Chek Instant) via Bluetooth. As an EU company without US business interests, D3S was able to serve patients in Iran despite US sanctions. The partnership demonstrates D3S's ability to develop medical device integrations and navigate export control regulations.
• NovartiscoreStrategic or Co-development PartnerD3S was named a Novartis Global Supplier following successful Inception CRM implementation in embargo markets. The partnership expanded to include Sandoz and Alcon affiliates. Ernst & Young conducted independent IT/Security audit resulting in Data3s qualification as global supplier.
• T-Mobile Czech RepubliccoreStrategic or Co-development PartnerPartnered with Prague Innovation Institute and T-Mobile Czech Republic on Cogni project for neurodegenerative disease detection. T-Mobile provided infrastructure support for the cognitive impairment screening application system.
• Prague Innovation InstitutecoreStrategic or Co-development PartnerD3S collaborated with Prague Innovation Institute to research, develop, and implement Cogni system for predicting and detecting neurodegenerative disease. D3S created native applications based on research developed by the Institute.
• GooglecoreStrategic or Co-development PartnerD3S developed strategic alliances with Czech online content providers for Google iGoogle platform. D3S facilitated partnerships, developed Google Gadget applications, and promoted iGoogle to attract users. Project contributed to Google's market share rise from 24% to 71% in Czech Republic.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Veeva Systems: Industry-standard CRM and content platform for life sciences; the dominant competitor to D3S's Inception CRM in pharma sales-force automation. Direct overlap on pharma sales workflows, CLM, and regulated content delivery.
• Cegedim: European-headquartered provider of CRM and data solutions for pharma (incl. Mobile Intelligence CRM); directly comparable to D3S given shared European pharma-CRM focus and cross-platform field sales tooling.

Broad incumbents

• Accenture Life Sciences: Global systems integrator delivering custom CRM and digital transformations for pharma; comparable on the custom-development and CRM-implementation services side of D3S's offering.
• Salesforce: Horizontal CRM leader with Health Cloud and Life Sciences Cloud offerings. Pharma clients can adopt Salesforce-based custom stacks similar to D3S's deployments, making it a broader incumbent alternative.
• Avanade: Joint venture between Accenture and Microsoft delivering Microsoft-stack-based enterprise solutions; comparable to D3S given shared Microsoft (.NET, Azure, Xamarin) technology stack and enterprise CRM delivery.
• IQVIA: Global life sciences technology and clinical services giant with CRM, CTMS, and commercial analytics offerings; competes with both D3S's Inception CRM and Clinical Studies CTMS at large pharma accounts.
• Oracle Health Sciences: Provides Siebel-based life sciences CRM and clinical trial/cloud solutions; competes with D3S's Inception CRM and Clinical Studies CTMS at large pharma and CRO accounts.
• Microsoft Dynamics 365: Enterprise CRM/ERP suite that D3S integrates against and that enterprise pharma clients may choose as a horizontal alternative to a vertical CRM like Inception.

Regional players

• NNIT (now part of Novo Nordisk): European (Denmark-based) IT services and life sciences technology provider with strong pharma heritage; comparable as a regional custom-dev and life-sciences-software peer to D3S in Europe.

Emerging players

• CitiusTech: Healthcare technology services and product company with growing life sciences footprint; overlaps with D3S on custom healthcare/diabetes app development and clinical data platforms.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/D3S_group
• Facebookfacebook.com/D3Sgroup
• LinkedInlinkedin.com/company/d3s-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about D3S Group